Emerging in the landscape of obesity treatment, retatrutide presents a different approach. Different from many current medications, retatrutide functions as a twin agonist, at once targeting both GLP-like peptide-1 https://brontemrdy472924.widblog.com/93416516/a-novel-retatrutide-the-glp-and-gip-receptor-agonist